Cetaphil for Crepey Skin

Recruiting at 1 trial location

Age: 18 - 65

Sex: Any

Trial Phase: Phase 4

Sponsor: Galderma R&D

Must not be taking: Blood thinners, Immunosuppressives

Disqualifiers: Pregnancy, Cancer history, Skin conditions, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Prior Safety Data This treatment has passed at least one previous human trial

Compensation: Varies

Number of Visits: 4

Duration: 12 weeks

30 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

Subjects having mild-to-moderate crepiness, photodamage, and loss of firmness will apply a topical skincare regimen to the knees, thighs, hands, and all over the body. Evaluations of the regimen's efficacy will be conducted at 4 weeks, 8 weeks, and 12 weeks post-baseline.

Are You a Good Fit for This Trial?

Adults aged 40-60 with mild-to-moderate crepey skin, wrinkles, and signs of aging due to sun exposure can join this study. Participants must be in good health and willing to switch their skincare routine exclusively to the trial's product for its duration. All skin types are welcome, but there's a special effort to include diverse racial and ethnic groups.

Inclusion Criteria

I am between 40 and 60 years old.

I am of any ethnicity, with efforts to include Hispanic, Latino, or Spanish origin.

I have a history of easily bruised or fragile skin.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants apply a topical skincare regimen to the knees, thighs, hands, and all over the body

12 weeks

Evaluations at 4 weeks, 8 weeks, and 12 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Cetaphil

Trial Overview

The trial is testing the effectiveness of Cetaphil as a topical treatment for improving the appearance of mature, crepey skin on various body parts over 12 weeks. Participants will apply it regularly and undergo assessments at different stages to measure changes.

How Is the Trial Designed?

Group I: Skincare Product Treatment Experimental Treatment 1 Intervention

Subjects will apply topical skincare products to the body.

Who Is Running the Clinical Trial?

Galderma R&D

Lead Sponsor

Trials

303

Recruited

60,700+

Flemming Ørnskov

Galderma R&D

Chief Executive Officer since 2019

MD, MPH

Baldo Scassellati Sforzolini

Galderma R&D

Chief Medical Officer

MD, PhD